Literature DB >> 22214279

Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis.

Catherine Giannopoulou1, Carla Patricia Martinelli-Klay, Tommaso Lombardi.   

Abstract

OBJECTIVES: To evaluate the expression of the receptor activator of NF-κB (RANK), the receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG), in the gingival tissue of patients with periodontitis.
MATERIALS AND METHODS: Gingival tissue was obtained from 14 systemically healthy subjects with chronic periodontitis during conventional periodontal surgery. Immunohistochemistry was used to detect the expression of RANK, RANKL and OPG in the oral and periodontal pocket epithelium as well as in the connective tissue cells.
RESULTS: RANKL was negatively expressed in both oral and periodontal pocket epithelium. OPG was also negative or weakly positive in the whole epithelium. RANK showed moderate/strong positive staining mainly in the basal and suprabasal layer of oral and periodontal pocket epithelium. In most of the cases, more than 60% of the inflammatory cell infiltrate stained for RANK and RANKL. In these cases the intensity of the stained cells ranged from moderate-to-strong. In less than half of the cases, OPG was positive in more than 60% of the stained cells of the inflammatory cell infiltrate.
CONCLUSION: The RANK, RANKL and OPG proteins are differentially expressed in periodontal tissues and may play a major role in the bone loss occurring in periodontitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22214279     DOI: 10.3109/00016357.2011.645064

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  7 in total

1.  A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis.

Authors:  Justin R Savage; Abigail Pulsipher; Narayanam V Rao; Thomas P Kennedy; Glenn D Prestwich; Maria E Ryan; Won Yong Lee
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

2.  RANK/RANKL/OPG Signalization Implication in Periodontitis: New Evidence from a RANK Transgenic Mouse Model.

Authors:  Bouchra Sojod; Danielle Chateau; Christopher G Mueller; Sylvie Babajko; Ariane Berdal; Frédéric Lézot; Beatriz Castaneda
Journal:  Front Physiol       Date:  2017-05-24       Impact factor: 4.566

3.  Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling.

Authors:  Jiahong Meng; Chenhe Zhou; Wenkan Zhang; Wei Wang; Bin He; Bin Hu; Guangyao Jiang; Yangxin Wang; Jianqiao Hong; Sihao Li; Jiamin He; Shigui Yan; Weiqi Yan
Journal:  J Cell Mol Med       Date:  2019-07-21       Impact factor: 5.310

4.  IL29 expression in gingival tissues of chronic periodontitis and aggressive periodontitis patients: An immunohistochemical analysis.

Authors:  Zahra Alizadeh Tabari; Somayeh Hematzadeh; Forooz Keshani
Journal:  Dent Res J (Isfahan)       Date:  2021-08-18

5.  The expression levels of MicroRNA-146a, RANKL and OPG after non-surgical periodontal treatment.

Authors:  Mandana Sattari; Ramezan Ali Taheri; Reza ArefNezhad; Hossein Motedayyen
Journal:  BMC Oral Health       Date:  2021-10-13       Impact factor: 2.757

6.  The use of mucoadhesive oral patches containing epigallocatechin-3-gallate to treat periodontitis: an in vivo study.

Authors:  Dur Muhammad Lashari; Mohammed Aljunaid; Yasmeen Lashari; Huda Rashad Qaid; Rini Devijanti Ridwan; Indeswati Diyatri; Nejva Kaid; Baleegh Abdulraoof Alkadasi
Journal:  J Taibah Univ Med Sci       Date:  2022-07-07

7.  Gingival cell growth with antiresorptive treatment combined with corticosteroids or antiestrogen.

Authors:  Heidi M Ekholm; Eliisa Löyttyniemi; Tero Soukka; Jaana Rautava
Journal:  Clin Exp Dent Res       Date:  2021-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.